Kansas
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
Cancer data are not available for Kansas for 2023
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in Kansas is 52.2 and not significantly different than the national rate of 52.1.
- It ranks 22nd among all states, placing it in the average tier.
- The change in the rate of new cases over the last five years is not available for Kansas.
- Note: When examining incidence data, it is important to note that the COVID-19 pandemic disrupted access to medical care. This resulted in a drop in cancer diagnoses for the year 2020, particularly for cancers diagnosed before symptoms develop (including lung cancer). This drop reflects changes in medical care for 2020 and should not necessarily be interpreted as a reduction in the underlying cancer burden.
Five-Year Survival Rate:
- The percent of people living five years after being diagnosed with lung cancer (the survival rate) in Kansas is 28.7%, which is significantly lower than the national rate of 31.0%.
- It ranks 28th among the 43 states with survival data, placing it in the below average tier.
- Over the last five years, the survival rate in Kansas improved by 14%.
Early Diagnosis:
- Nationally, 29.3% of cases are diagnosed at an early stage.
- The early diagnosis rate is not available for Kansas .
Lung Cancer Treatment
Biomarker Coverage:
Kansas has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of September 2026.
Surgical Treatment:
- Nationally, 21.4% of cases undergo surgery as part of the first course of treatment.
- Data on surgery as part of the first course of treatment is not available for Kansas.
No Treatment:
- Nationally, 20.9% of cases receive no treatment.
- Data on lack of treatment is not available for Kansas.
Screening
Screening for High Risk:
- In Kansas, 25.4% of those at high risk were screened, which was not significantly different than the national rate of 24.4%.
- It ranks 19th (out of the 50 states with available data), placing it in the average tier.
Prevention
Tobacco Use:
- The 2025 smoking rate in Kansas is 11.7% and significantly higher than the national rate of 10.4%.
- It ranks 31st (out of the 48 states with available data), placing it in the average tier.
Radon:
- In Kansas, 34.5% of radon tests results were at or above the action level recommended by EPA.
- It ranks 35th among all states, placing it in the below average tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 59.3 per 100,000 population among Black individuals in Kansas, not significantly different than the rate of 53.5 among Black individuals nationally, and not significantly different than the rate of 53.1 among white individuals in Kansas.
- The five-year survival rate is 31.9% among Black individuals in Kansas, not significantly different than the rate of 28.5% among Black individuals nationally, and not significantly different than the rate of 28.5% among white individuals in Kansas.
Lung cancer data (including early diagnosis, surgery, lack of treatment) is incomplete or unavailable for Black individuals in Kansas due to data limitations.
Latino individuals:
- The rate of new lung cancer cases is 29.1 per 100,000 population among Latino individuals in Kansas, not significantly different than the rate of 27.8 among Latino individuals nationally, and significantly lower than the rate of 53.1 among white individuals in Kansas.
- State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
Lung cancer data (including early diagnosis, surgery, lack of treatment) is incomplete or unavailable for Latino individuals in Kansas due to data limitations.
Asian or Pacific Islander individuals:
- The rate of new lung cancer cases is 37.8 per 100,000 population among Asian or Pacific Islanders individuals in Kansas, not significantly different than the rate of 32.7 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 53.1 among white individuals in Kansas.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- Lung cancer data (including early diagnosis, surgery, lack of treatment) is incomplete or unavailable for Asian or Pacific Islander individuals in Kansas due to data limitations.
Indigenous Peoples:
- Lung cancer data (including rates, early diagnosis, surgery, lack of treatment) is incomplete or unavailable for Indigenous Peoples (American Indians/Alaska Natives) in Kansas due to data limitations.
Summary
Early diagnosis data is not available for Kansas. When this rate increases, we can anticipate that the surgery rate would increase, as surgery is often the recommended treatment for those diagnosed at an earlier stage. In addition, when cases are found earlier, we would expect the five-year survival rate to increase.
Kansas has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
Page last updated: November 10, 2026